BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23049838)

  • 1. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system.
    D'Amato NC; Ostrander JH; Bowie ML; Sistrunk C; Borowsky A; Cardiff RD; Bell K; Young LJ; Simin K; Bachelder RE; Delrow J; Dawson A; Yee LD; Mrózek K; Clay TM; Osada T; Seewaldt VL
    PLoS One; 2012; 7(9):e45684. PubMed ID: 23049838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
    Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
    Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
    Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
    Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
    Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
    Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.
    Tachtsidis A; Le AV; Blick T; Gunasinghe D; De Sousa E; Waltham M; Dobrovic A; Thompson EW
    Clin Exp Metastasis; 2019 Aug; 36(4):393-409. PubMed ID: 31190270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
    Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
    Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
    Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
    EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.
    Yamamoto M; Sakane K; Tominaga K; Gotoh N; Niwa T; Kikuchi Y; Tada K; Goshima N; Semba K; Inoue JI
    Cancer Sci; 2017 Jun; 108(6):1210-1222. PubMed ID: 28371195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.
    Zhang W; Qian P; Zhang X; Zhang M; Wang H; Wu M; Kong X; Tan S; Ding K; Perry JK; Wu Z; Cao Y; Lobie PE; Zhu T
    J Biol Chem; 2015 May; 290(22):13812-29. PubMed ID: 25873390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
    Lv ZD; Kong B; Liu XP; Jin LY; Dong Q; Li FN; Wang HB
    J Cell Mol Med; 2016 May; 20(5):864-73. PubMed ID: 26820102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.
    Hollier BG; Tinnirello AA; Werden SJ; Evans KW; Taube JH; Sarkar TR; Sphyris N; Shariati M; Kumar SV; Battula VL; Herschkowitz JI; Guerra R; Chang JT; Miura N; Rosen JM; Mani SA
    Cancer Res; 2013 Mar; 73(6):1981-92. PubMed ID: 23378344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity.
    Strietz J; Stepputtis SS; Follo M; Bronsert P; Stickeler E; Maurer J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).
    Oliveras-Ferraros C; Corominas-Faja B; Cufí S; Vazquez-Martin A; Martin-Castillo B; Iglesias JM; López-Bonet E; Martin ÁG; Menendez JA
    Cell Cycle; 2012 Nov; 11(21):4020-32. PubMed ID: 22992620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAE1 mediated ZEB1 expression promotes epithelial-mesenchymal transition in breast cancer.
    Oh JH; Lee JY; Yu S; Cho Y; Hur S; Nam KT; Kim MH
    Sci Rep; 2019 Feb; 9(1):2977. PubMed ID: 30814639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells.
    Yang M; Ma B; Shao H; Clark AM; Wells A
    BMC Cancer; 2016 Jul; 16():419. PubMed ID: 27387344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.